Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri Solution for Solid Tumor Oncology Research. Learn More
X
Scientific presentation

Dr. Takahashi uses single-cell DNA sequencing to unambiguously identify major triple mutant clone


Koichi Takahashi, MD
Description

In this early proof-of-concept study, Dr. Koichi Takahashi from MD Anderson uses the newly available Tapestri Platform for high-throughput single-cell DNA sequencing of acute myeloid leukemia (AML) tumors. Sophisticated microfluidics and droplet technology allow researchers to encapsulate individual cells into droplets and enhance previous low-throughput single-cell technologies that relied on microwells to encapsulate single cells. In his presentation, Dr. Takahashi shows tantalizing data that comes when single nucleotide variants (SNVs) are uncovered on a per-cell basis. These data allow for the clonality of the sample to be uncovered instead of being inferred from bulk sequencing technologies. In addition, rare clones containing multiple co-occurring mutations are detected at a sensitivity of 0.1%



VIEW


Scientific presentation
Single cell Genotypic and Immunotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia
Ross Levine, MD
Tapestri scMRD for AML Summit (2022)
Scientific presentation
Bioinformatics approach to demultiplexing scMRD
Troy Robinson, MSKCC
Tapestri scMRD for AML Summit (2022)
Scientific presentation
Opportunities for Single-cell Multi-omics in the Clinic: MRD and Beyond
Ross Levine
Marina Konopleva
Saar Gill
Wenbin Xiao
Mikhail Roshal
Tapestri scMRD for AML Summit (2022)
Scientific presentation
Single-cell Multi-omics and the Horizon of Clinical Utility
Aaron Llanso
(2022)
REQUEST QUOTE